Merck KGaA confirmed and detailed its guidance for 2024 after it reported lower sales and earnings for the first quarter, hit by inventory reductions at its life-science segment.
Merck KGaA confirmed and detailed its guidance for 2024 after it reported lower sales and earnings for the first quarter, hit by inventory reductions at its life-science segment.